Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 5,178,000 | 5,777,000 | 6,232,000 | 5,051,000 | 5,405,000 |
| Cost of Goods | 1,134,000 | 1,225,000 | 1,249,000 | 950,000 | 894,000 |
| Gross Profit | 4,044,000 | 4,552,000 | 4,983,000 | 4,101,000 | 4,511,000 |
| Operating Expenses | 3,348,000 | 3,866,000 | 3,834,000 | 3,176,000 | 3,594,000 |
| Operating Income | 696,000 | 686,000 | 1,149,000 | 925,000 | 917,000 |
| Interest Expense | 343,000 | 302,000 | 418,000 | 448,000 | 340,000 |
| Other Income | 21,000 | 23,000 | 15,000 | 15,000 | 5,000 |
| Pre-tax Income | 374,000 | 407,000 | 746,000 | 492,000 | 582,000 |
| Income Tax | 58,000 | -854,000 | 97,000 | 46,000 | 70,000 |
| Net Income Continuous | 316,000 | 1,261,000 | 649,000 | 446,000 | 512,000 |
| Minority Interests | -24,000 | -40,000 | -37,000 | -31,000 | -25,000 |
| Net Income | $340,000 | $1,301,000 | $686,000 | $477,000 | $537,000 |
| EPS Basic Total Ops | 0.14 | 0.51 | 0.27 | 0.19 | 0.21 |
| EPS Basic Continuous Ops | 0.12 | 0.50 | 0.26 | 0.18 | 0.20 |
| EPS Diluted Total Ops | 0.14 | 0.51 | 0.27 | 0.19 | 0.21 |
| EPS Diluted Continuous Ops | 0.12 | 0.50 | 0.26 | 0.18 | 0.20 |
| EBITDA(a) | $1,405,000 | $1,793,000 | $1,804,000 | $1,541,000 | $1,575,000 |